1-(4-Hydroxy-2-methyl-1,1-dioxo-2H-1,2-benzothiazin-3-yl) ethanone

被引:11
作者
Ahmad, Matloob [1 ]
Siddiqui, Hamid Latif [1 ]
Zia-ur-Rehman, Muhammad [2 ]
Ashiq, Muhammad Irfan [3 ]
Tizzard, Graham John [3 ]
机构
[1] Univ Punjab, Inst Chem, Lahore 54590, Pakistan
[2] Appl Chem Res Ctr, Lahore 54600, Pakistan
[3] Univ Southampton, Sch Chem, Southampton SO9 5NH, Hants, England
来源
ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE | 2008年 / 64卷
关键词
D O I
10.1107/S1600536808007721
中图分类号
O7 [晶体学];
学科分类号
0702 ; 070205 ; 0703 ; 080501 ;
摘要
In the title compound, C11H11NO4S, the thiazine ring adopts a distorted half-chair conformation. The enolic H atom is involved in an intramolecular O-H center dot center dot center dot O hydrogen bond, forming a six-membered ring. Molecules are linked through weak intermolecular C-H center dot center dot center dot O hydrogen bonds, resulting in chains lying along the b axis.
引用
收藏
页码:O788 / U1286
页数:9
相关论文
共 13 条
[1]  
[Anonymous], 1999, J. Appl. Crystallogr, DOI [DOI 10.1107/S0021889899006020, 10.1107/S0021889899006020]
[2]   1,2-Benzothiazine 1,1-dioxide α-ketoamide analogues as potent calpain I inhibitors [J].
Bihovsky, R ;
Tao, M ;
Mallamo, JP ;
Wells, GJ .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (04) :1035-1038
[3]   4-hydroxy-2-methyl-N-(5-methyl-1,3-thiazol-2-yl)-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide [J].
Fabiola, GF ;
Pattabhi, V ;
Manjunatha, SG ;
Rao, GV ;
Nagarajan, K .
ACTA CRYSTALLOGRAPHICA SECTION C-CRYSTAL STRUCTURE COMMUNICATIONS, 1998, 54 :2001-2003
[4]   STRUCTURE OF METHYL 4-HYDROXY-2-METHYL-2H-1,2-BENZOTHIAZINE-3-CARBOXYLATE 1,1-DIOXIDE [J].
GOLIC, L ;
LEBAN, I .
ACTA CRYSTALLOGRAPHICA SECTION C-STRUCTURAL CHEMISTRY, 1987, 43 :280-282
[5]  
Nonius, 1998, COLLECT
[6]   Processing of X-ray diffraction data collected in oscillation mode [J].
Otwinowski, Z ;
Minor, W .
MACROMOLECULAR CRYSTALLOGRAPHY, PT A, 1997, 276 :307-326
[7]  
PEARCE LJ, 1993, CAMERON
[8]  
Sheldrick G.M., 2007, SADABS
[9]  
Sheldrick GM, 2015, ACTA CRYSTALLOGR C, V71, P3, DOI [10.1107/S2053229614024218, 10.1107/S0108767307043930]
[10]  
TURCK D, 1996, CLIN PHARM, V36, P79